Edition:
United Kingdom

Amedica Corp (AMDA.OQ)

AMDA.OQ on NASDAQ Stock Exchange Capital Market

2.93USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$2.93
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
11,668
52-wk High
$8.86
52-wk Low
$2.91

Latest Key Developments (Source: Significant Developments)

Amedica submits 510(k) application to FDA for Valeo C+CSC with Lumen
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Amedica Corp :Amedica submits 510(k) application to FDA for Valeo C+CSC with Lumen.  Full Article

Amedica announces workforce reduction by about 38 pct
Wednesday, 5 Oct 2016 

Amedica Corp : Amedica announces workforce reduction . Reduced its workforce by approximately 38% to lower its operating expenses . Reduced its workforce by approximately 38% . Actions associated with plan were implemented on october 3, 2016 and completed on october 4, 2016 .Estimates staff reductions to result in savings of approximately $2.0 million in cash operating expenses.  Full Article

Amedica says Q2 product rev was $4 mln vs. $4.8 mln
Thursday, 11 Aug 2016 

Amedica Corp : Amedica Corporation reports second quarter 2016 financial results . Total product revenue was $4.0 million in Q2 of 2016 as compared to $4.8 million in same period of 2015 . Qtrly loss per share $0.40 .Says "we expect that our commercial sales expansion strategy will be substantially completed during Q3".  Full Article

Alpha Capital Anstalt reports 9.9 pct passive stake in Amedica
Thursday, 14 Jul 2016 

: Alpha Capital Anstalt reports 9.9 pct passive stake in Amedica as of July 8, 2016 - SEC Filing Source - http://bit.ly/29KuALz Further company coverage: [AMDA.O] (Bengaluru Newsroom; +1 646 223 8780).  Full Article

Amedica submits response to FDA for clearance of spinal device
Monday, 13 Jun 2016 

Amedica Corp : Submitted its responses to Food And Drug Administration (FDA) in relation to cascade clinical trial . If approved, would commence manufacturing, marketing and sales of product in united states and its possessions subject to FDA jurisdiction . Amedica says anticipates a final determination from FDA within next 60 days .Amedica submits response to FDA for clearance of composite interbody spinal device.  Full Article

BRIEF-Amedica announces reverse stock split

* Amedica Corp - ‍announced a 1-for-12 reverse stock split of its issued and outstanding common stock​ Source text for Eikon: Further company coverage: